187 related articles for article (PubMed ID: 21426933)
21. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
22. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
[TBL] [Abstract][Full Text] [Related]
24. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
25. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
26. Oestrogen exerts anti-inflammation via p38 MAPK/NF-κB cascade in adipocytes.
Mu PW; Jiang P; Wang MM; Chen YM; Zheng SH; Tan Z; Jiang W; Zeng LY; Wang TH
Obes Res Clin Pract; 2016; 10(6):633-641. PubMed ID: 27004692
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
[TBL] [Abstract][Full Text] [Related]
29. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
30. RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells.
Gogineni VR; Kargiotis O; Klopfenstein JD; Gujrati M; Dinh DH; Rao JS
Int J Oncol; 2009 Jan; 34(1):209-18. PubMed ID: 19082492
[TBL] [Abstract][Full Text] [Related]
31. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
32. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
33. VEGF-initiated angiogenesis and the uPA/uPAR system.
Breuss JM; Uhrin P
Cell Adh Migr; 2012; 6(6):535-615. PubMed ID: 23076133
[TBL] [Abstract][Full Text] [Related]
34. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
Marumo T; Schini-Kerth VB; Busse R
Diabetes; 1999 May; 48(5):1131-7. PubMed ID: 10331420
[TBL] [Abstract][Full Text] [Related]
36. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Li H; Chen C
Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
[TBL] [Abstract][Full Text] [Related]
37. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
38. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
39. Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly.
Wang L; Pedroja BS; Meyers EE; Garcia AL; Twining SS; Bernstein AM
PLoS One; 2012; 7(3):e33915. PubMed ID: 22470492
[TBL] [Abstract][Full Text] [Related]
40. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]